Literature DB >> 25654604

Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremia.

Marta Mora-Rillo1, Natalia Fernández-Romero, Carolina Navarro-San Francisco, Jesús Díez-Sebastián, Maria Pilar Romero-Gómez, Francisco Arnalich Fernández, Jose Ramon Arribas López, Jesús Mingorance.   

Abstract

Extraintestinal pathogenic Escherichia coli (ExPEC) are a frequent cause of bacteremia and sepsis, but the role of ExPEC genetic virulence factors (VFs) in sepsis development and outcome is ill-defined. Prospective study including 120 adult patients with E. coli bacteremia to investigate the impact of bacterial and host factors on sepsis severity and mortality. Patients' clinical and demographic data were registered. Phylogenetic background of E. coli isolates was analyzed by SNP pyrosequencing and VFs by PCR. The E. coli isolates presented an epidemic population structure with 6 dominant clones making up to half of the isolates. VF gene profiles were highly diverse. Multivariate analysis for sepsis severity showed that the presence of cnf and blaTEM genes increased the risk of severe illness by 6.75 (95% confidence interval [CI] 1.79-24.71) and 2.59 (95% CI 1.04-6.43) times respectively, while each point in the Pitt score increased the risk by 1.34 (95% CI 1.02-1.76) times. Multivariate analysis for mortality showed that active chemotherapy (OR 17.87, 95% CI 3.35-95.45), McCabe-Jackson Index (OR for rapidly fatal category 120.15, 95% CI 4.19-3446.23), Pitt index (OR 1.78, 95% CI 1.25-2.56) and presence of fyuA gene (OR 8.05, 95% CI 1.37-47.12) were associated to increased mortality while the presence of P fimbriae genes had a protective role (OR 0.094, 95%IC 0.018-0.494). Bacteremic E. coli had a high diversity of genetic backgrounds and VF gene profiles. Bacterial VFs and host determinants had an impact on disease evolution and mortality.

Entities:  

Keywords:  E coli; bloodstream infection; mortality; outcome; systemic inflammatory response syndrome; virulence factor

Mesh:

Substances:

Year:  2015        PMID: 25654604      PMCID: PMC4603433          DOI: 10.4161/21505594.2014.991234

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  30 in total

1.  Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia.

Authors:  T A Hekker; A B Groeneveld; A M Simoons-Smit; P de Man; H Connell; D M MacLaren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-04       Impact factor: 3.267

2.  Commensal bacteria in the gut: learning who our friends are.

Authors:  Fang Yan; D Brent Polk
Journal:  Curr Opin Gastroenterol       Date:  2004-11       Impact factor: 3.287

3.  Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes.

Authors:  Daniel Aubert; Thierry Naas; Claire Héritier; Laurent Poirel; Patrice Nordmann
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

4.  Severity of Escherichia coli bacteraemia is independent of the intrinsic virulence of the strains assessed in a mouse model.

Authors:  L Landraud; F Jauréguy; E Frapy; G Guigon; S Gouriou; E Carbonnelle; O Clermont; E Denamur; B Picard; E Lemichez; S Brisse; X Nassif
Journal:  Clin Microbiol Infect       Date:  2012-01-23       Impact factor: 8.067

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 6.  Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.

Authors:  J W Chow; V L Yu
Journal:  Int J Antimicrob Agents       Date:  1999-01       Impact factor: 5.283

7.  Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis.

Authors:  M Ananias; T Yano
Journal:  Braz J Med Biol Res       Date:  2008-10       Impact factor: 2.590

8.  Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis.

Authors:  F Jauréguy; E Carbonnelle; S Bonacorsi; C Clec'h; P Casassus; E Bingen; B Picard; X Nassif; O Lortholary
Journal:  Clin Microbiol Infect       Date:  2007-07-06       Impact factor: 8.067

Review 9.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

10.  Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin.

Authors:  Line Skjøt-Rasmussen; Karen Ejrnæs; Bettina Lundgren; Anette M Hammerum; Niels Frimodt-Møller
Journal:  Int J Med Microbiol       Date:  2012-05-08       Impact factor: 3.473

View more
  21 in total

1.  The importance of the "V"-Factor: Escherichia coli bacteremia and sepsis.

Authors:  Stephen F Murphy; Praveen Thumbikat
Journal:  Virulence       Date:  2015       Impact factor: 5.882

2.  Serine protease autotransporters of Enterobacteriaceae (SPATEs) are largely distributed among Escherichia coli isolated from the bloodstream.

Authors:  Claudia A Freire; Ana Carolina M Santos; Antonio C Pignatari; Rosa M Silva; Waldir P Elias
Journal:  Braz J Microbiol       Date:  2020-01-21       Impact factor: 2.476

3.  Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection.

Authors:  B Owrangi; N Masters; A Kuballa; C O'Dea; T L Vollmerhausen; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-16       Impact factor: 3.267

4.  Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.

Authors:  Jie Ma; Ning Li; Yajie Liu; Chong Wang; Xiaoyan Liu; Shengmei Chen; Xinsheng Xie; Silin Gan; Meng Wang; Weijie Cao; Fang Wang; Yanfan Liu; Dingming Wan; Ling Sun; Hui Sun
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

5.  Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: Prospective observational study.

Authors:  Eun-Jeong Yoon; Min Hyuk Choi; Yoon Soo Park; Hye Sun Lee; Dokyun Kim; Hyukmin Lee; Kyeong Seob Shin; Jong Hee Shin; Young Uh; Young Ah Kim; Jeong Hwan Shin; Seok Hoon Jeong
Journal:  EBioMedicine       Date:  2018-08-20       Impact factor: 8.143

6.  A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines.

Authors:  Robin Vanstokstraeten; N Belasri; T Demuyser; F Crombé; K Barbé; D Piérard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-06-26       Impact factor: 3.267

Review 7.  Pathogenesis of Gram-Negative Bacteremia.

Authors:  Caitlyn L Holmes; Mark T Anderson; Harry L T Mobley; Michael A Bachman
Journal:  Clin Microbiol Rev       Date:  2021-03-10       Impact factor: 26.132

8.  Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections.

Authors:  Dmitriy Li; Cameron J Reid; Timothy Kudinha; Veronica M Jarocki; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-11-18

9.  Antimicrobial activity of apple cider vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; downregulating cytokine and microbial protein expression.

Authors:  Darshna Yagnik; Vlad Serafin; Ajit J Shah
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

10.  No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia.

Authors:  Shi Thong Heng; Swaine L Chen; Joshua G X Wong; David C Lye; Tat Ming Ng
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.